Chlamydia trachomatis infections of the female genital tract: State of the art

References

• Land JA, Van Bergen JEAM, Morre SA, Postma MJ. Epidemiology of Chlamydia trachomatis infection in women and the cost-effectiveness of screening. Hum Reprod Update. 2010:16:189–204.
   PubMed Web of Science ®Google Scholar
• Kalwij S, Macintosh M, Baraitser P. Screening and treatment of Chlamydia trachomatis infections. BMJ. 2010;340:912–7.
   Google Scholar
• ECDC Guidance: Chlamydia control in Europe, 2009. Available at: www.ecdc.europa.eu. (Accessed date: 29 December 2010).
   Google Scholar
• Morre SA, Rozendaal L, Van Valkengoed IG, Boeke AJ, Van Voorst Vader PC, Schirm J, . Urogenital Chlamydia trachomatis serovars in men and women with a symptomatic or asymptomatic infection: an association with clinical manifestations? J Clin Microbiol. 2000;38:2292–6.
   PubMed Web of Science ®Google Scholar
• Wilson JS, Honey E, Templeton A, Paavonen J, Mårdh PA, Stary A, .; EU Biomed Concerted Action Group. A systematic review of the prevalence of Chlamydia trachomatis among European women. Hum Reprod Update. 2002;28: 385–94.
   Google Scholar
• van Bergen J, Spaargaren J, Götz HM, Veldhuijzen IK, Bindels PJE, Coenen TJ, .; the PILOT CT study-group. Population prevalence of Chlamydia trachomatis and Neisseria gonorrhoeae in the Netherlands. BMC Infect Dis. 2006;6:42.
   PubMedGoogle Scholar
• van Bergen J, Gotz HM, Richardus JH, Hoebe CJ, Broer J, Coenen AJ. Prevalence of urogenital Chlamydia trachomatis increases significantly with level of urbanisation and suggests targeted screening approaches: results from the first national population based study in the Netherlands. Sex Transm Infect. 2005;81:17–23.
   PubMed Web of Science ®Google Scholar
• Andersen B, Olesen F, Moller JK, Ostergaard L. Population-based strategies for outreach screening of urogenital Chlamydia trachomatis infections: a randomized, controlled trial. J Infect Dis. 2002;185:252–8.
   PubMedGoogle Scholar
• Macleod J, Salisbury C, Low N, McCarthy A, Sterne JA, Holloway A, . Coverage and uptake of systematic postal screening for Chlamydia trachomatis and prevalence of infection in the United Kingdom general population: cross sectional study. BMJ. 2005;330:940–2.
   PubMedGoogle Scholar
• Low N; the SCREen project team. Publication report on chlamydia control activities in Europe. Euro Surveill. 2008; 13: pii: 18924.
   Google Scholar
• Tu W, Batteiger B, Wiehe S, Ofner S, Van Der Pol B, Katz BP, . Time from first intercourse to first sexually transmitted infection diagnosis among adolescent women. Arch Pediatr Adolesc Med. 2009;163:1106–11.
   PubMedGoogle Scholar
• Centers for Disease Control and Prevention (CDC). Chlamydia screening among sexually active young female enrollees of health plans—United States, 2000–2007. MMWR Morb Mortal Wkly Rep. 2009;58:362–5.
   PubMedGoogle Scholar
• Aral SO, Fenton KA, Holmes KK. Sexually transmitted disease in the USA. Temporal trends. Sex Transm Infect. 2007;83:257–66.
   PubMedGoogle Scholar
• Paavonen J; FUTURE II Study Group. Baseline demographic characteristics of subjects enrolled in international quadrivalent HPV (types 6/11/16718) vaccine trials. Curr Med Res Opin. 2008;24:1–12.
   PubMedGoogle Scholar
• Paavonen J, Naud P, Salmerón J, Wheeler CM, Chow SN, Apter D, . Efficacy of human papillomavirus (HPV)-16/18 AS04-adjuvanted vaccine against cervical infection and precancer caused by oncogenic HPV types (PATRICIA). Final analysis of a double-blind, randomised study in young women. Lancet. 2009;374:301–14.
   PubMed Web of Science ®Google Scholar
• Egger M, Low N, Smith GD, Lindblom B, Hermann B. Screening for chlamydial infections and the risk of ectopic pregnancy in a county in Sweden: ecological analysis. BMJ. 1998;316:1776–80.
   PubMed Web of Science ®Google Scholar
• Simms I, Talebi A, Rhia J, Horner P, French RS, Sarah R, . The English National Screening Programme: variation in positivity in 2007/2008. Sex Transm Dis. 2009;36: 522–7.
   PubMedGoogle Scholar
• Franklin N, O’Connor CC, Shaw M, Guy R, Grulich A, Fairley CK, . Chlamydia at an inner metropolitan sexual health clinic Sydney, NSW; the Australain collaboration for chlamydia enhanced sentinal surveillance (ACCESS) Project. Proceedings of the Twelfth International Symposium on Human Chlamydial Infections, International Chlamydia Symposium, Hof bei Salzburg, Austria, 20–25 June 2010. 413.
   Google Scholar
• Batteiger BE, Tu W, Ofner S, Van Der Pol B, Stothard D, Orr DP, . Repeated Chlamydia trachomatis genital infections in adolescent women. J Infect Dis. 2010;201:42–51.
   PubMed Web of Science ®Google Scholar
• Lyytikäinen E, Kaasila M, Koskela P, Lehtinen M, Patama T, Pukkala E, . Chlamydia trachomatis seroprevalence atlas of Finland 1983–2003. Sex Transm Infect. 2008; 84: 19–22.
   PubMedGoogle Scholar
• Kretzshmar M, Turner KME, Barton PM, Edmunds WJ, Low N. Predicting the population impact of chlamydia screening programmes: comparative mathematical modelling study. Sex Transm Infect. 2009;85:359–66.
   PubMedGoogle Scholar
• Hu D, Hook EW III, Goldie SJ. Screening for Chlamydia trachoamatis in women 15 to 29 years of age: a cost- effectiveness analysis. Ann intern Med. 2004;141:501–14.
   PubMed Web of Science ®Google Scholar
• Adams EJ, Tirner KME, Edmonds WJ. The cost effective ness of opportunistic Chlamydia screening in England. Sex Transm Inf. 2007;83:267–75.
   PubMedGoogle Scholar
• De Vries R, Van Bergen JEAM, De Jong-van den Berg LTW, Postma PJ; the PILOT-CT study Group. Cost-utility of repeated screening for Chlamydia trachomatis. Value Health. 2008;11:272–4.
   PubMedGoogle Scholar
• Paavonen J. Memorable Chlamydia trachomatis papers. Sex Transm Infect. 2000;76:S30–2.
   Google Scholar
• Wiesenfeld H, Paavonen J. Pelvic inflammatory disease. Morse SA, Ballard RC, Holmes KK, Moreland A. Atlas of sexually transmitted disease and AIDS. 4th. London, UK: Elsevier Ltd. 2010, 94–110. In press.
   Google Scholar
• van Valkengoed I, Morré S, van den Brule A, Meijer CJ, Bouter LM, Boeke AJ. Overestimation of complication rates in evaluations of Chlamydia trachomatis screening programmes—implications for cost-effectiveness analyses. Int J Epidemiol. 2004;33:416–25.
   PubMed Web of Science ®Google Scholar
• Low N, Egger M, Sterne JA, Harbord RM, Ibrahim F, Lindblom B, . Incidence of severe reproductive tract complications associated with diagnosed genital chlamydial infection: the Uppsala Women's Cohort Study. Sex Transm Infect. 2006;82:212–8.
   PubMed Web of Science ®Google Scholar
• Bakken IJ, Ghaderi S. Incidence of pelvic inflammatory disease in a large cohort of women tested for Chlamydia trachomatis: a historical follow-up study. BMC Infect Dis. 2009;9:130–4.
   PubMedGoogle Scholar
• Bjartling C, Osser S, Persson K. Chlamydia trachomatis is still in common in pelvic inflammatory disease in the south of Sweden. Proceedings of the Twelfth International Symposium on Human Chlamydial Infections, International Chlamydia Symposium, Hof bei Salzburg, Austria, 20–25 June 2010. 389.
   Google Scholar
• Mårdh P-A, Ripa T, Svensson L, Weström L. Chlamydia trachomatis infection in patients with acute salpingitis. N Engl J Med. 1977;296:1377–9.
   PubMed Web of Science ®Google Scholar
• Öhman H, Tiitinen A, Halttunen M, Lehtinen M, Paavonen J, Surcel HM. Cytokine polymorphisms and severity of tubal damage in women with chlamydia-associated infertility. J Infect Dis. 2009;199:1353–9.
   PubMed Web of Science ®Google Scholar
• Öhman H, Tiitinen A, Halttunen M, Birgelund S, Christiansen G, Koskela P, . IL-10 polymorphism and cell mediated immune response to chlamydia trachomatis. Genes Immun. 2006;7:243–9.
   PubMedGoogle Scholar
• Wang W, Stassen FR, Surcel H-M, Öhman H, Tiitinen A, Paavonen J, . Analyses of polymorphism in inflammasome-associated NLRP3 and miRNA-146A genes in the susceptibility to and tubal pathology of Chlamydia trachomatis infection. Drugs Today (Barc). 2009;45, Suppl B: 95–103.
   Google Scholar
• Öhman H, Bailey R, Natividad A, Tiitinen A, Halttunen M, Paavonen J, . Il-12p40 polymorphisms and C. trachomatis specific lymphocyte proliferative responses. Proceedings of the Twelfth International Symposium on Human Chlamydial Infections, International Chlamydia Symposium, Salzburg, Austria, 20–25 June 2010. Abstract. 169–72.
   Google Scholar
• Schachter J, Hill EC, King EB, Coleman VR, Jones P, Meyer KF. Chlamydia infection in women with cervical dysplasia. Am J Obstet Gynecol. 1975;123:753–7.
   PubMed Web of Science ®Google Scholar
• Paavonen J, Vesterinen E, Meyer B, Saikku P, Suni J, Purola E, . Genital Chlamydia trachomatis infections in patients with cervical atypia. Obstet Gynecol. 1979;54:289–91.
   PubMed Web of Science ®Google Scholar
• Koskela P, Anttila T, Björge T, Brunsvig A, Dillner J, Hakama M, . Chlamydia trachomatis infection and invasive cervical cancer. Int J Cancer. 2000;85:35–9.
   PubMed Web of Science ®Google Scholar
• Anttila T, Saikku P, Koskela P, Bloigu A, Dillner J, Ikäheimo I, . Serotypes of Chlamydia trachomatis and risk for cervical squamous cell carcinoma. JAMA. 2001;285: 47–51.
   PubMed Web of Science ®Google Scholar
• Paavonen J, Karunakaran KP, Noguchi Y, Anttila T, Bloigu A, Dillner J, . Serum antibody response to the heat shock protein 60 of Chlamydia trachomatis in women with developing cervical cancer. Am J Obstet Gynecol. 2003; 189:1287–92.
   PubMed Web of Science ®Google Scholar
• Johanson KA, Chen AL, Tan M, Sütterlin C. The role of the protease CPAF in chlamydia-induced centronome amplification. Proceedings of the Twelfth International Symposium on Human Chlamydial Infections, Hof bei Salzburg, Austria, 20–25 June 2010. Oral presentation.
   Google Scholar
• Schiffman M, Castle PE, Jeronimo J, Rodriguez A, Wacholder S. Human papillomavirus and cervical cancer. Lancet. 2007;370:890–907.
   PubMed Web of Science ®Google Scholar
• Lehtinen M, Lyytikäinen E, Koskela P, Surcel H-M, Paavonen J. Chlamydia trachomatis and risk for cervical neoplasia—a meta-analysis of longitudinal studies. Proceedings of the Twelfth International Symposium on Human Chlamydial Infections, International Chlamydia Symposium, Salzburg, Austria, 20–25 June 2010. Abstract. 445–8.
   Google Scholar
• Risch HA, Howe GR. Pelvic inflammatory disease and the risk of epithelial ovarian cancer. Cancer Epidemiol Biomarkers Prevent. 1995;4:447–51.
   PubMedGoogle Scholar
• Ness RB, Shen C, Bass, Jackson C, Moysich K, Edwards R, . Chlamydia trachomatis serology in women with and without ovarian cancer. Infect Dis Obstet Gynecol. 2008; 16:1–5.
   Google Scholar
• Idahl A, Lundin E, Elgh F, Jurstrand M, Møller JK, Marklund I, . Chlamydia trachomatis, Mycoplasma genitalium, Neisseria gonorrhoeae, human papillomavirus, and polyomavirus are not detectable in human tissue with epithelial ovarian cancer, borderline tumor, or benign conditions. Am J Obstet Gynecol. 2010;202:71.e1–6.
   Google Scholar
• Riska A, Finne P, Alfthan H, Anttila T, Jalkanen J, Sorvari T, . Past chlamydial infection is not associated with primary fallopian tube carcinoma. Eur J Cancer. 2006;42:1835–8.
   PubMed Web of Science ®Google Scholar
• Morin-Papunen L, Duleba A, Bloigu A, Järvelin MR, Saikku P, Pouta A. Chlamydia antibodies and self-reported symptoms of oligo-amenorrhea and hirsutism: a new etiologic factor in polycystic ovary syndrome. Fertil Steril. 2010;94: 1799–804.
   PubMedGoogle Scholar
• Tikkanen M, Surcel H-M, Boigu A, Nuutila M, Hiilesmaa V, Ylikorkala O, . Prediction of placental abruption by testing for C-reactive protein and chlamydial antoibody levels in early pregnancy. BJOG. 2008;115:486–91.
   PubMedGoogle Scholar
• Paavonen J, Eggert-Kruse W. Chlamydia trachomatis infection—impact on human reproduction. Hum Reprod Update. 1999;5:433–47.
   PubMed Web of Science ®Google Scholar
• Joki-Korpela P, Sahrakorpi N, Halttunen M, Surcel HM, Paavonen J, Tiitinen A. The role of Chlamydia trachomatis in male infertity. Fertil Steril. 2009;91:S1448–50.
   PubMed Web of Science ®Google Scholar
• Tiitinen A, Surcel H-M, Halttunen M, Birkelund S, Bloigu A, Christiansen G, . Chlamydia trachomatis and chlamydial heat shock protein 60-specific antibody and cell-mediated responses predict tubal factor infertility. Hum Reprod. 2006;21:1533–8.
   PubMedGoogle Scholar
• Jespersen DJ, Flatten KS, Jones MF, Smith TF. Prospective comparison of cell culture and nucleic acid amplification tests for laboratory diagnosis of Chlamydia trachomatis infections. J Clin Microbiol. 2005;43:5324–6.
   PubMedGoogle Scholar
• Chernesky M, Jang D, Smieja M, Portillo E, Ewert R, Pritchard C, . Validation of the APTIMA Combo 2 assay for the detection of Chlamydia trachomatis and Neisseria gonorrhoeae in SurePath liquid-based pap test samples taken with different collection devices. Sex Transm Dis. 2009;36:581–3.
   PubMed Web of Science ®Google Scholar
• Masek BJ, Arora N, Quinn N, . Performance of three nucleic acid amplification tests for detection of Chlamydia trachomatis and Neisseria gonorrhoeae by use of self- collected vaginal swabs obtained via an internet-based screening program. J Clin Microbiol. 2009;47:1663–7.
   PubMed Web of Science ®Google Scholar
• Quint K, Porras C, Safaeian M, González P, Hildesheim A, Quint W, . Evaluation of a novel PCR-based assay for detection and identification of Chlamydia trachomatis serovars in cervical specimens. J Clin Microbiol. 2007;45:3986–91.
   PubMed Web of Science ®Google Scholar
• Quint K, van Doorn L-J, Kleter B, de Koning MN, van den Munckhof HA, Morre SA . A highly sensitive, multiplex broad-spectrum PCR-DNA-enzyme immunoassay and reverse hybridization assay for rapid detection and identification of Chlamydia trachomatis serovars. J Mol Diagn. 2007;9:631–8.
   PubMedGoogle Scholar
• Mahilum-Tapay L, Laitila V, Wawrzyniak JJ, Lee HH, Alexander S, Ison C, . New point of care Chlamydia Rapid Test—bridging the gap between diagnosis and treatment: performance evaluation study. BMJ. 2007;335: 1190–4.
   PubMedGoogle Scholar
• Morré SA, Catsburg A, de Boer M, Spaargaren J, de Vries HJ, Schirm J, . Monitoring the potential introduction of the Swedish Chlamydia trachomatis variant (swCT) in the Netherlands. Euro Surveill. 2007;12:318–20.
   Google Scholar
• de Barbeyrac B, Raherison S, Cado S, Normandin F, Clerc M, Clairet V, . French situation concerning the Swedish Chlamydia trachomatis variant. Euro Surveill. 2007;12:321–2.
   Google Scholar
• Reischl U, Straube E, Unemo M. The Swedish new variant of Chlamydia trachomatis (nvCT) remains undetected by many European laboratories as revealed in the recent PCR/NAT ring trial organised by INSTAND e.V., Germany. Euro Surveill. 2009; 14; pii: 19302.
   Google Scholar
• Lagergård T, Hadad R, Tunbäck P, Lindholm L, Löwhagen GB, Unemo M. Distribution of Chlamydia trachomatis ompA genovars and the new variant of C. trachomatis in the Göteborg area, Sweden. Eur J Clin Microbiol Infect Dis. 2010;29:609–11.
   PubMedGoogle Scholar
• Bjartling C, Osser S, Johnsson A, Persson K. Clinical manifestation and epidemiology of the new genetic variant of chlamydia trachomatis. Sex Transm Dis. 2009;36:529–35.
   PubMedGoogle Scholar
• Christerson L, Klint M, Hadad R, Lor B, Anagrius C, Österlund A, . The proportion of the new variant of Chlamydia trachomatis is converging in Sweden counties over time. Proceedings of the Twelfth International Symposium on Human Chlamydial Infections, International Chlamydia Symposium, Hof bei Salzburg, Austria, 20–25 June 2010. 401.
   Google Scholar
• Clarke IN, Hammas B, Beerens AMJ, Luijt DS, Westh H, Nilsson P, . Detection and spread of new variant Chlamydia trachomatis in northern European countries. Proceedings of the Twelfth International Symposium on Human Chlamydial Infections, International Chlamydia Symposium, Hof bei Salzburg, Austria, 20–25 June 2010. 397.
   Google Scholar
• Johnson AM, Horner P. A new role for Chlamydia trachomatis serology. Sex Transm Infect. 2008;84:79–80.
   PubMed Web of Science ®Google Scholar
• Traharne JD, Ripa KT, Mårdh PA, Svensson L, Weström L, Darougar S. Antibodies to Chlamydia trachomatis in acute salpingitis. Br J Vener Dis. 1979;55:26–9.
   PubMedGoogle Scholar
• Akande VA, Hunt LP, Cahill DJ, Caul EO, Ford WCL, Jenkins JM. Tubal damage in infertile women: prediction using chlamydia serology. Hum Reprod. 2003;18:1841–7.
   PubMed Web of Science ®Google Scholar
• Gijsen AP, Land JA, Goossens VJ, Slobbe MEP, Bruggeman CA. Chlamydia antibody testing in screening for tubal factor subfertility: the significance of IgG antibody decline over time. Hum Reprod. 2002;17:699–703.
   PubMedGoogle Scholar
• Piura B, Sarov B, Sarov I. Persistance of antichlamydial antibodies after treatment of acute salpingitis with doxycycline. Eur J Obstet Gynecol Reprod Biol. 1993;48:117–21.
   PubMedGoogle Scholar
• Henry-Suchet J, Askienay-Elbhar M, Thibon M, Revol C, Akue BA. The post-therapeutic course of serum antibody titres in women with acute salpingitis and tubal infertility. Fertil Steril. 1994;62:296–304.
   PubMed Web of Science ®Google Scholar
• Tobin JM, Harinda V, Mani R. Which treatment for genital tract Chlamydia trachomatis infection? Int J STD AIDS. 2004;15:737–9.
   PubMedGoogle Scholar
• Lamontagne S, Baster K, Emmett L, Nichols T, Randell S, McLean L, . Incidence and reinfection rates of genital chlamydial infection among women aged 16–24 years attending general practice, family planning and genitourinary medicine clinics in England: a prospective cohort study by the Chlamydia Recall Study Advisory Group. Sex Transm Infect. 2007;83:292–303.
   PubMed Web of Science ®Google Scholar
• Centers for Disease Control and Prevention. Chlam ydia screening fact sheet. Available at: www.cdc.gov/std/Chlamydia/STDFact-Chlamydia.htm.
   Google Scholar
• Igietseme JU, He Q, Joseph K, Eko FO, Lyn D, Ananaba G, . Role of T lymphocytes in the pathogenesis of chlamydia disease. J Infect Dis. 2009;200:926–34.
   PubMed Web of Science ®Google Scholar
• Brunham RC, Rey-Ladino J. Immunology of Chlamydia infection: implications for a Chlamydia trachomatis vaccine. Nature. 2005;5:149–61.
   Google Scholar
• European Centre for Disease Prevention and Control. Chlamydia control in Europe. Available at: 2009. wwwecdc.europa.eu/en/publications/Publications(0906_GUI_Chlamydia_Control_in_Europe.pdf.
   Google Scholar
• Gaydos CA, Wright C, Wood B, Waterfield G, Hobson S, Quinn TC. Chlamydia trachomatis reinfection rates among female adolescents seeking rescreening in school-based health centers. Sex Transm Dis. 2008;35:233–7.
   PubMed Web of Science ®Google Scholar
• Fung M, Scott K, Kent C, Klausner JD. Chlamydial and gonococcal reinfection among men: a systematic review of data to evaluate the need for retesting. Sex Transm Infect. 2007;83:304–9.
   PubMed Web of Science ®Google Scholar
• Brunham R, Rekart M. The arrested immunity hypothesis and the epidemiology of chlamydia control. Sex Transm Dis. 2008;35:53–4.
   PubMed Web of Science ®Google Scholar
• Lyytikäinen E, Kaasila M, Hiltunen-Back E, Lehtinen M, Tasanen K, Surcel HM, . A discrepancy of Chlamydia trachomatis incidence and prevalence trends in Finland 1983–2003. BMC Infect Dis. 2008;8:169–74.
   PubMedGoogle Scholar
• Golden MR, Whittington WL, Handsfield HH, Hughes JP, Stamm WE, Hogben M, . Effect of expedited treatment of sex partners on recurrent or persistent gonorrhea or chlamydial infection. N Engl J Med. 2005;352:676–85.
   PubMed Web of Science ®Google Scholar
• Cameron ST, Glasier A, Scott G, Young H, Melvin L, Johnstone A, . Novel interventions to reduce re-infection in women with chlamydia: a randomized controlled trial. Hum Reprod. 2009;24:888–95.
   PubMedGoogle Scholar
• Owens SL, Arora N, Quinn N, Peeling RW, Holmes KK, Gaydos CA. Utilising the internet to test for sexually transmitted infections: results of a survey and accuracy testing. Sex Transm Infect. 2010;86:112–6.
   PubMed Web of Science ®Google Scholar
• Arnheim L. Immunological responses in genital HPV infections and etiology of cervical cancer. Thesis. Stockholm: Karolinska Institute; 2005.
   Google Scholar
• Lehtinen M, Dillner J, Knekt P, Luostarinen T, Aromaa A, Kirnbauer R, . Serologically diagnosed infection with human papillomavirus type 16 and risk for subsequent development of cervical carcinoma: nested case-control study. BMJ. 1996;312:537–9.
   PubMed Web of Science ®Google Scholar
• Naucler P, Chen H-C, Persson K, You SL, Hsieh CY, Sun CA, . Seroprevalence of human papillomavirus and Chlamydia trachomatis and cervical cancer risk: nested case-control study. J Gen Virol. 2007;88:814–22.
   PubMedGoogle Scholar
• Koutsky LA, Holmes KK, Critchlow CW, Stevens CE, Paavonen J, Beckmann AM, . A cohort study of the risk of cervical intraepithelial neoplasia grade 2 or 3 in relation to papillomavirus infection. N Engl J Med. 1992;327:1272–8.
   PubMed Web of Science ®Google Scholar
• Lehtinen M, Ault K, Lyytikäinen E, Dillner J, Garland SM, Ferris DG, . Chlamydia trachomatis infection and risk of cervical intraepithelial neoplasia. Sex Transm Infect. In press.
   Google Scholar
• Samoff E, Koumans EH, Markowitz LE, Sternberg M, Sawyer MK, Swan D, . Association of Chlamydia trachomatis with persistence of high-risk of human papillomavirus in a cohort of female adolescents. Am J Epidemiol. 2005;162:668–75.
   PubMed Web of Science ®Google Scholar
• Silins I, Ryd W, Strand A, Törnberg S, Hansson BG, Wang X, . Chlamydia trachomatis infection and persistence of human papillomavirus. Int J Cancer. 2005;116:110–5.
   PubMed Web of Science ®Google Scholar